Kyle Gano, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 65,000 shares at $141.50 ($9.2M) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Scheduled sale ($9.2M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.50 | 4,812 | $681K | 7.4% |
| 2 | $141.50 | 60,188 | $8.5M | 92.6% |
| Total | $141.50 avg | 65,000 | $9.2M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $598K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |